EQT to buy diagnostics player Qiagen for €9.6bn
This deal comes after a period of notable interest in Qiagen from private equity firms.
This deal comes after a period of notable interest in Qiagen from private equity firms.
The British government will now change up AI-enabled medical device regulation to encourage innovation with the appropriate guardrails.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
Australia starts investigation into OpenAI Medicare breach
Industry partnership will determine the success of the transition to low-GWP pMDIs
UK government champions healthtech through new NHS access programme